These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3162171)

  • 1. Hepatitis B: a scientific success story (almost).
    Purcell RH
    Prog Clin Biol Res; 1985; 182():11-43. PubMed ID: 3162171
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 4. XVI Annual American Red Cross Scientific Symposium: Infection, immunity, blood transfusion. Introduction.
    Barker LF
    Prog Clin Biol Res; 1985; 182():xix-xxv. PubMed ID: 3898127
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral hepatitis: 2. Hepatitis B vaccines.
    Samaranayake LP
    Dent Update; 1986 Oct; 13(9):411-4, 416. PubMed ID: 2948850
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine preventable diseases: current perspectives in historical context, Part I.
    Weisberg SS
    Dis Mon; 2007 Sep; 53(9):422-66. PubMed ID: 17996745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute viral hepatitis B].
    Gaye-Bareyt E
    Soins; 1990 Mar; (534):4-12. PubMed ID: 2141184
    [No Abstract]   [Full Text] [Related]  

  • 9. [20 years after the discovery of the Australia antigen].
    Grob PJ
    Schweiz Rundsch Med Prax; 1987 Dec; 76(50):1402-6. PubMed ID: 2962263
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of hepatitis B by recombinant DNA hepatitis B vaccine.
    Schalm SW; Heijtink RA
    Neth J Med; 1986; 29(2):42-8. PubMed ID: 3951652
    [No Abstract]   [Full Text] [Related]  

  • 11. [Infection by hepatitis B virus and its prevention].
    Kashiwagi S
    Rinsho Byori; 1987 Jan; 35(1):9-16. PubMed ID: 3560486
    [No Abstract]   [Full Text] [Related]  

  • 12. Reflections on Wolf Szmuness.
    Kellner A
    Prog Clin Biol Res; 1985; 182():3-10. PubMed ID: 3162173
    [No Abstract]   [Full Text] [Related]  

  • 13. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Microbiol Sci; 1985 May; 2(5):129-30, 133-8. PubMed ID: 2978963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral hepatitis: overview and historical perspectives.
    Krugman S
    Yale J Biol Med; 1976 Jul; 49(3):199-203. PubMed ID: 785825
    [No Abstract]   [Full Text] [Related]  

  • 17. Human hepatitis B vaccine from recombinant yeast. 1984.
    McAleer WJ; Buynak EB; Maigetter RZ; Wampler DE; Miller WJ; Hilleman MR
    Biotechnology; 1992; 24():500-2. PubMed ID: 1422061
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis B--the current situation.
    Jilg W; Deinhardt F
    Infection; 1986; 14(3):100-1. PubMed ID: 2942487
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis B virus. Application of recombinant DNA technics to the development of hepatitis B vaccines and its diagnosis].
    Hamada F
    Rinsho Byori; 1988 May; 36(5):548-52. PubMed ID: 2971829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.